Advanced search
Publication Cover
Postgraduate Medicine Volume 130, 2018 - Issue 3
Submit an article Journal homepage
159
Views
0
CrossRef citations to date
0
Altmetric
Clinical Features - Original Research

Cutaneous irritancy of an ibuprofen medicated plaster in healthy volunteers

Manisha MaganjiMedical Science, Reckitt Benckiser, Slough, UKView further author information
,
Mark P. ConnollyGlobal Market Access Solutions, St-Prex, Switzerland;Department of Pharmacy, Unit of Pharmacoepidemiology & Pharmacoeconomics, University of Groningen, Groningen, The NetherlandsCorrespondence[email protected] [email protected]
ORCID Iconhttp://orcid.org/0000-0002-1886-745XView further author information
ORCID Icon &
Aomesh BhattMedical Affairs and Clinical Research, R&D at Reckitt Benckiser, Slough, UKView further author information
Pages 334-340 | Received 17 Dec 2017, Accepted 05 Feb 2018, Published online: 12 Feb 2018

References

  • Paoloni JA, Milne C, Orchard J, et al. Non-steroidal anti-inflammatory drugs in sports medicine: guidelines for practical but sensible use. Br J Sports Med. 2009 Oct;43(11):863–865.
  • Yong CS, Oh Y-K, Jung SH, et al. Preparation of ibuprofen-loaded liquid suppository using eutectic mixture system with menthol. Eur J Pharm Sci. 2004;23(4–5):347–353.
  • Newa M, Bhandari KH, Li DX, et al. Preparation, characterization and in vivo evaluation of ibuprofen binary solid dispersions with poloxamer 188. Int J Pharm. 2007;343(1–2):228–237.
  • Whitefield M, O’Kane CJ, Anderson S. Comparative efficacy of a proprietary topical ibuprofen gel and oral ibuprofen in acute soft tissue injuries: a randomized, double-blind study. J Clin Pharm Ther. 2002;27(6):409–417.
  • Thomas T, Mottram D, Waldock C. Advising patients on prevention and management of sporting injuries in the pharmacy. Pharm J. 2016;297(7892):1–11.
  • Massey T, Derry S, Moore RA, et al. Topical NSAIDs for acute pain in adults. Cochrane Database Syst Rev. 2010;(6):CD007402. doi:10.1002/14651858.CD007402.pub2
  • Busson M. Update on ibuprofen: review article. J Int Med Res. 1986;14(2):53–62.
  • Bradbury F. How important is the role of the physician in the correct use of a drug? An observational cohort study in general practice. Int J Clin Pract Suppl. 2004;144:27–32.
  • Bushra R, Aslam N. An overview of clinical pharmacology of Ibuprofen. Oman Med J. 2010;25(3):155–1661.
  • Patel A, Bell M, O’Connor C, et al. Delivery of ibuprofen to the skin. Int J Pharm. 2013;457(1):9–13.
  • Pierce CA, Voss B. Efficacy and safety of ibuprofen and acetaminophen in children and adults: a meta-analysis and qualitative review. Ann Pharmacother. 2010;44(3):489–506.
  • Ong CK, Lirk P, Tan CH, et al. An evidence-based update on nonsteroidal anti-inflammatory drugs. Clin Med Res. 2007;5(1):19–34.
  • Heyneman CA, Lawless-Liday C, Wall GC. Oral versus topical NSAIDs in rheumatic diseases: a comparison. Drugs. 2000;60(3):555–574.
  • Derry S, Moore RA, Rabbie R. Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database Syst Rev. 2012;(9):CD007400.
  • Mason L, Moore RA, Edwards JE, et al. Topical NSAIDs for acute pain: a meta-analysis. BMC Fam Pract. 2004;5:10.
  • Predel HG, Connolly MP, Bhatt A, et al. Efficacy and safety assessment of acute sports-related traumatic soft tissue injuries using a new ibuprofen medicated plaster: results from a randomized controlled clinical trial. Phys Sportsmed. 2017;45(4):418–425.
  • Gniazdowska B, Rueff F, Przybilla B. Delayed contact hypersensitivity to non-steroidal anti-inflammatory drugs. Contact Dermatitis. 1999;40(2):63–65.
  • McCormack K, Kidd BL, Morris V. Assay of topically administered ibuprofen using a model of post-injury hypersensitivity. A randomised, double-blind, placebo-controlled study. Eur J Clin Pharmacol. 2000;56(6–7):459–462.
  • Maganji M, Connolly MP, Bhatt A. Cutaneous irritancy of an ibuprofen medicated plaster in healthy volunteers. Postgrad Med. 2017;130(1):19–23.
  • Shelanski HA, Shelanski MV. A new technique of human patch tests. Proc Sei Sect Toilet Goods Assoc. 1953;19:46–49.
  • Guidance for Industry: FDA Guidance: Skin Irritation and Sensitization Testing of Generic Transdermal Drug Products. 1999. [cited 2017 Jul 3]. https://www.fda.gov/ohrms/dockets/98fr/990236Gd.pdf
  • Ale I, Lachapelle JM, Maibach HI. Skin tolerability associated with transdermal drug delivery systems: an overview. Adv Ther. 2009;26(10):920–935.
  • Bershow A, Warshaw E. Cutaneous reactions to transdermal therapeutic systems. Dermatitis. 2011;22(4):193–203.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.